Abstract:This comprehensive review critically examines the transformative impact of artificial intelligence (AI) and radiomics in the diagnosis, prognosis, and management of bladder, kidney, and prostate cancers. These cutting-edge technologies are revolutionizing the landscape of cancer care, enhancing both precision and personalization in medical treatments. Our review provides an in-depth analysis of the latest advancements in AI and radiomics, with a specific focus on their roles in urological oncology. We discuss how AI and radiomics have notably improved the accuracy of diagnosis and staging in bladder cancer, especially through advanced imaging techniques like multiparametric MRI (mpMRI) and CT scans. These tools are pivotal in assessing muscle invasiveness and pathological grades, critical elements in formulating treatment plans. In the realm of kidney cancer, AI and radiomics aid in distinguishing between renal cell carcinoma (RCC) subtypes and grades. The integration of radiogenomics offers a comprehensive view of disease biology, leading to tailored therapeutic approaches. Prostate cancer diagnosis and management have also seen substantial benefits from these technologies. AI-enhanced MRI has significantly improved tumor detection and localization, thereby aiding in more effective treatment planning. The review also addresses the challenges in integrating AI and radiomics into clinical practice, such as the need for standardization, ensuring data quality, and overcoming the "black box" nature of AI. We emphasize the importance of multicentric collaborations and extensive studies to enhance the applicability and generalizability of these technologies in diverse clinical settings. In conclusion, AI and radiomics represent a major paradigm shift in oncology, offering more precise, personalized, and patient-centric approaches to cancer care. While their potential to improve diagnostic accuracy, patient outcomes, and our understanding of cancer biology is profound, challenges in clinical integration and application persist. We advocate for continued research and development in AI and radiomics, underscoring the need to address existing limitations to fully leverage their capabilities in the field of oncology.

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: How to improve the accuracy and personalization level of diagnosis, prognosis, and treatment management of bladder cancer, kidney cancer, and prostate cancer through artificial intelligence (AI) and radiomics technologies. ### Specific problems include: 1. **Bladder cancer**: - How to use AI and radiomics technologies to more accurately distinguish normal tissues from bladder cancer. - How to distinguish non - muscle - invasive bladder cancer (NMIBC) and muscle - invasive bladder cancer (MIBC) through advanced imaging techniques (such as multi - parameter MRI and CT scans). - How to evaluate post - treatment changes, especially in distinguishing post - treatment changes from muscle - invasive bladder cancer. 2. **Kidney cancer**: - How to distinguish different subtypes and grades of renal cell carcinoma (RCC) through AI and radiomics technologies. - How to combine radiogenomics to provide a comprehensive view of disease biology, thereby achieving personalized treatment. 3. **Prostate cancer**: - How to use AI - enhanced MRI technology to improve the accuracy of tumor detection and localization, thereby improving treatment plans. - How to distinguish low - grade and high - grade lesions through machine - learning models combined with radiomics features, especially in the prediction of peripheral zone lesions. ### Summary The core objective of the paper is to explore the application potential of AI and radiomics in urological cancers (bladder cancer, kidney cancer, and prostate cancer) and address the challenges existing in current clinical practice, such as data standardization, quality assurance, and the "black - box" property of AI. Through these technologies, the research hopes to achieve earlier cancer detection, more informed treatment decisions, and potentially improve the prognosis of patients.

Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review

Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

A Comprehensive Review of Artificial Intelligence in Prostate Cancer Care: State-of-the-Art Diagnostic Tools and Future Outlook

Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies

Uptake of 99mTc-DTPA in Bone Metastases from Renal Cancer.

Role of AI and Radiomic Markers in Early Diagnosis of Renal Cancer and Clinical Outcome Prediction: A Brief Review

Artificial intelligence in cancer imaging: Clinical challenges and applications

[Advances in artificial intelligence-assisted MRI radiomics in the diagnosis and treatment of prostate cancer]

A review of Artificial Intelligence methods in bladder cancer: segmentation, classification, and detection

The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer

A narrative review on current imaging applications of artificial intelligence and radiomics in oncology: focus on the three most common cancers

Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement

Views on the Diagnostic Labels of Autism and Asperger’s Disorder and the Proposed Changes in the DSM

Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives

Artificial Intelligence in Head and Neck Cancer Diagnosis: A Comprehensive Review with Emphasis on Radiomics, Histopathological, and Molecular Applications

Artificial Intelligence in Breast Cancer Diagnosis and Treatment: Advances in Imaging, Pathology, and Personalized Care

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review

Artificial Intelligence in CT and MR Imaging for Oncological Applications

Unlocking the Potential of AI in Cancer Therapeutics: Advancements in Treatment Selection, Swift Diagnosis, Risk Assessment, and Prognosis

A systematic review of current advancements of artificial intelligence in genitourinary cancers